Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thalidomide for the Prevention of Restenosis After Coronary Artery Stent Implantation
NCT01638078Phase 4Unknown
- Sponsor
- Sapienza University of Rome
- Start
- Jan 2014
- Primary completion
- Jun 2015
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of thalidomide in coronary artery restenosis, sponsored by Sapienza University of Rome. Status: unknown.
02
Drugs
thalidomide
03
Conditions
coronary artery restenosis
Beyond the preview
Go deeper on NCT01638078.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01638078.